Study uncovers how SNHG10 drives tumour progression and chemotherapy resistance, offering a potential new therapeutic target. Study uncovers how SNHG10 drives tumour progression and chemotherapy resistance, offering a potential new therapeutic target.
A Thu, study studied this question.